|
Mr. Soinski brings 23 years of general management, business development and marketing experience to SHPI, including several years as the President and CEO of ViroTex Corporation (ViroTex), a venture-backed pharmaceutical company focused on the development and commercialization of proprietary drug delivery systems. Mr. Soinski merged ViroTex into Atrix Laboratories, Inc. (NASDAQ: ATRX) in 1998, and continued working with Atrix on a transitional basis through 1999. Prior to joining SHPI, he was the Managing Partner and CEO of Mad Dogs & Englishmen, a marketing communications firm with offices in New York and San Francisco. Mr. Soinski has a BA degree from Dartmouth College. | 